Improving alcohol intervention to prevent HIV in Vietnam
Scaling up the brief alcohol intervention to prevent HIV infection in Vietnam: a cluster randomized, implementation trial
This study is testing a new way to help people with HIV in Vietnam cut down on their drinking, which can help them stick to their HIV treatment better, and it’s designed to make sure healthcare providers are ready to support their patients in this journey.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10894328 on NIH RePORTER |
What this research studies
This research focuses on enhancing a brief alcohol intervention designed to help individuals with HIV reduce their alcohol consumption, which can improve their adherence to antiretroviral therapy. The study will implement a cluster randomized trial in ART clinics in Vietnam, where clinical staff will receive training and support to effectively deliver this intervention. By addressing the attitudes of healthcare providers towards alcohol use, the research aims to facilitate the broader adoption of this intervention in clinical settings. Patients will benefit from improved access to support for managing alcohol use, which is crucial for their overall health and HIV management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who also engage in unhealthy alcohol use.
Not a fit: Patients who do not have HIV or those who do not consume alcohol may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better health outcomes for people living with HIV by reducing alcohol use and improving adherence to treatment.
How similar studies have performed: Previous research has shown that brief alcohol interventions can effectively reduce alcohol use and improve health outcomes for people living with HIV, indicating a promising approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Go, Vivian F. — Univ of North Carolina Chapel Hill
- Study coordinator: Go, Vivian F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.